Shadi Abdar Esfahani, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Radiology | 5 | 2022 | 2131 | 1.010 |
Why?
|
Stomach Neoplasms | 2 | 2022 | 1356 | 0.840 |
Why?
|
Organometallic Compounds | 1 | 2023 | 663 | 0.670 |
Why?
|
Nuclear Medicine | 1 | 2021 | 232 | 0.630 |
Why?
|
Neuroendocrine Tumors | 1 | 2023 | 607 | 0.570 |
Why?
|
Radiation Oncology | 2 | 2022 | 556 | 0.560 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2022 | 2033 | 0.470 |
Why?
|
Myoblasts, Skeletal | 1 | 2014 | 76 | 0.460 |
Why?
|
Anal Canal | 2 | 2014 | 382 | 0.460 |
Why?
|
Household Articles | 1 | 2012 | 24 | 0.440 |
Why?
|
Cell Tracking | 1 | 2014 | 145 | 0.430 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2016 | 571 | 0.420 |
Why?
|
Ureterocele | 1 | 2011 | 28 | 0.410 |
Why?
|
Magnetite Nanoparticles | 1 | 2014 | 319 | 0.410 |
Why?
|
Dextrans | 1 | 2014 | 599 | 0.400 |
Why?
|
Leadership | 1 | 2021 | 1378 | 0.400 |
Why?
|
Epispadias | 1 | 2011 | 18 | 0.400 |
Why?
|
Cardiac Tamponade | 1 | 2012 | 174 | 0.400 |
Why?
|
Cystoscopy | 1 | 2011 | 133 | 0.390 |
Why?
|
Urinary Bladder, Neurogenic | 1 | 2012 | 167 | 0.380 |
Why?
|
Pericardium | 2 | 2012 | 672 | 0.380 |
Why?
|
Heart Injuries | 1 | 2012 | 209 | 0.370 |
Why?
|
Urinary Bladder, Overactive | 1 | 2012 | 111 | 0.370 |
Why?
|
Wounds, Penetrating | 1 | 2012 | 307 | 0.360 |
Why?
|
Bladder Exstrophy | 1 | 2011 | 108 | 0.360 |
Why?
|
Myoblasts | 1 | 2011 | 239 | 0.360 |
Why?
|
Urinary Bladder | 2 | 2012 | 1181 | 0.320 |
Why?
|
Urinary Incontinence | 1 | 2011 | 499 | 0.290 |
Why?
|
Rhabdomyosarcoma | 1 | 2009 | 387 | 0.270 |
Why?
|
Gallium Radioisotopes | 2 | 2023 | 179 | 0.270 |
Why?
|
Spinal Cord Injuries | 1 | 2012 | 945 | 0.240 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2016 | 2259 | 0.230 |
Why?
|
Infant, Newborn, Diseases | 1 | 2009 | 587 | 0.230 |
Why?
|
Radiography | 3 | 2022 | 7047 | 0.230 |
Why?
|
Positron-Emission Tomography | 7 | 2022 | 6364 | 0.220 |
Why?
|
Lactate Dehydrogenases | 1 | 2022 | 26 | 0.210 |
Why?
|
Magnetic Resonance Imaging | 6 | 2022 | 35798 | 0.210 |
Why?
|
Octreotide | 1 | 2023 | 150 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3136 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3246 | 0.210 |
Why?
|
Prenatal Diagnosis | 1 | 2009 | 1242 | 0.210 |
Why?
|
Hexokinase | 1 | 2022 | 126 | 0.200 |
Why?
|
Granzymes | 1 | 2023 | 271 | 0.200 |
Why?
|
Glucose Transporter Type 1 | 1 | 2022 | 193 | 0.200 |
Why?
|
Receptor, erbB-3 | 1 | 2022 | 142 | 0.200 |
Why?
|
Receptors, Peptide | 1 | 2023 | 277 | 0.200 |
Why?
|
Family Leave | 1 | 2021 | 18 | 0.200 |
Why?
|
Lactates | 1 | 2022 | 432 | 0.190 |
Why?
|
Pyruvic Acid | 1 | 2022 | 196 | 0.190 |
Why?
|
Rats, Sprague-Dawley | 1 | 2012 | 8285 | 0.190 |
Why?
|
Mice, Nude | 4 | 2022 | 3668 | 0.190 |
Why?
|
Liver Neoplasms | 1 | 2016 | 4311 | 0.180 |
Why?
|
Organizations | 1 | 2021 | 171 | 0.180 |
Why?
|
Sick Leave | 1 | 2021 | 109 | 0.180 |
Why?
|
Pandemics | 1 | 2020 | 8607 | 0.180 |
Why?
|
CA-19-9 Antigen | 2 | 2010 | 111 | 0.180 |
Why?
|
Disease Models, Animal | 5 | 2016 | 18174 | 0.170 |
Why?
|
Heart | 1 | 2012 | 4458 | 0.170 |
Why?
|
Kidney Pelvis | 2 | 2010 | 188 | 0.170 |
Why?
|
Lung Injury | 1 | 2023 | 434 | 0.160 |
Why?
|
Mice, Inbred NOD | 1 | 2023 | 1876 | 0.160 |
Why?
|
Ureteral Obstruction | 2 | 2010 | 296 | 0.160 |
Why?
|
Kidney | 1 | 2013 | 7152 | 0.150 |
Why?
|
Policy | 1 | 2021 | 516 | 0.140 |
Why?
|
Internship and Residency | 3 | 2022 | 5858 | 0.140 |
Why?
|
Colorectal Neoplasms | 1 | 2016 | 6855 | 0.140 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2009 | 2267 | 0.140 |
Why?
|
Cell Line, Tumor | 5 | 2022 | 16789 | 0.140 |
Why?
|
Radiation Injuries | 1 | 2023 | 1189 | 0.140 |
Why?
|
Leukocytes, Mononuclear | 1 | 2023 | 1843 | 0.140 |
Why?
|
Carbon Radioisotopes | 1 | 2017 | 577 | 0.130 |
Why?
|
Peritoneal Neoplasms | 1 | 2022 | 678 | 0.130 |
Why?
|
Humans | 39 | 2023 | 752741 | 0.130 |
Why?
|
Congresses as Topic | 1 | 2020 | 767 | 0.130 |
Why?
|
Lactams, Macrocyclic | 1 | 2017 | 319 | 0.130 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2022 | 2450 | 0.130 |
Why?
|
Mice | 10 | 2023 | 81766 | 0.120 |
Why?
|
Animals | 16 | 2023 | 169600 | 0.120 |
Why?
|
Tissue Scaffolds | 2 | 2012 | 964 | 0.120 |
Why?
|
Rabbits | 4 | 2014 | 4910 | 0.120 |
Why?
|
Fluorine Radioisotopes | 1 | 2017 | 445 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2022 | 2492 | 0.110 |
Why?
|
Burnout, Professional | 1 | 2022 | 703 | 0.110 |
Why?
|
Liver Neoplasms, Experimental | 1 | 2014 | 195 | 0.110 |
Why?
|
Cystostomy | 1 | 2012 | 26 | 0.110 |
Why?
|
Molecular Imaging | 2 | 2023 | 824 | 0.110 |
Why?
|
Breast Feeding | 1 | 2020 | 1335 | 0.100 |
Why?
|
Matrix Metalloproteinases | 1 | 2015 | 394 | 0.100 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2016 | 603 | 0.100 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2022 | 3753 | 0.100 |
Why?
|
Gastric Outlet Obstruction | 1 | 2012 | 56 | 0.100 |
Why?
|
Play and Playthings | 1 | 2012 | 79 | 0.100 |
Why?
|
Urinary Catheterization | 1 | 2012 | 202 | 0.100 |
Why?
|
Laminectomy | 1 | 2012 | 232 | 0.100 |
Why?
|
Rectal Neoplasms | 1 | 2020 | 1190 | 0.100 |
Why?
|
Tissue Engineering | 2 | 2012 | 1893 | 0.100 |
Why?
|
Gastrointestinal Agents | 1 | 2016 | 503 | 0.090 |
Why?
|
Coronary Artery Disease | 1 | 2011 | 6565 | 0.090 |
Why?
|
Histiocytosis | 1 | 2011 | 40 | 0.090 |
Why?
|
Urinary Bladder Diseases | 1 | 2011 | 167 | 0.090 |
Why?
|
Ureter | 1 | 2013 | 375 | 0.090 |
Why?
|
Guided Tissue Regeneration | 1 | 2010 | 85 | 0.090 |
Why?
|
Iron Overload | 1 | 2012 | 244 | 0.090 |
Why?
|
DNA Mismatch Repair | 1 | 2013 | 435 | 0.090 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 2 | 2011 | 265 | 0.090 |
Why?
|
Quality of Life | 1 | 2011 | 13044 | 0.090 |
Why?
|
beta-Thalassemia | 1 | 2012 | 226 | 0.090 |
Why?
|
Urodynamics | 1 | 2011 | 348 | 0.090 |
Why?
|
Intestinal Perforation | 1 | 2012 | 253 | 0.090 |
Why?
|
Genital Diseases, Male | 1 | 2010 | 84 | 0.090 |
Why?
|
Chondrocytes | 1 | 2015 | 804 | 0.090 |
Why?
|
Scrotum | 1 | 2010 | 121 | 0.090 |
Why?
|
Staining and Labeling | 1 | 2014 | 1104 | 0.090 |
Why?
|
Ferritins | 1 | 2012 | 590 | 0.090 |
Why?
|
Cell Adhesion Molecules | 1 | 2015 | 1614 | 0.080 |
Why?
|
Klinefelter Syndrome | 1 | 2009 | 49 | 0.080 |
Why?
|
Female | 17 | 2022 | 385090 | 0.080 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2016 | 15657 | 0.080 |
Why?
|
Graves Disease | 1 | 2010 | 245 | 0.080 |
Why?
|
Hypospadias | 1 | 2009 | 92 | 0.080 |
Why?
|
Disorders of Sex Development | 1 | 2009 | 122 | 0.080 |
Why?
|
Fecal Incontinence | 1 | 2010 | 240 | 0.080 |
Why?
|
B-Lymphocyte Subsets | 1 | 2009 | 249 | 0.080 |
Why?
|
Graves Ophthalmopathy | 1 | 2009 | 121 | 0.070 |
Why?
|
Foreign Bodies | 1 | 2012 | 405 | 0.070 |
Why?
|
Estradiol | 1 | 2015 | 2025 | 0.070 |
Why?
|
Receptors, Estrogen | 1 | 2015 | 2193 | 0.070 |
Why?
|
Intestines | 1 | 2016 | 1924 | 0.070 |
Why?
|
Transplantation, Autologous | 1 | 2011 | 2125 | 0.070 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2010 | 412 | 0.070 |
Why?
|
Treatment Outcome | 8 | 2016 | 64017 | 0.070 |
Why?
|
Radiography, Thoracic | 1 | 2012 | 1279 | 0.070 |
Why?
|
Anti-Inflammatory Agents | 1 | 2016 | 1812 | 0.070 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2009 | 647 | 0.070 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2011 | 1101 | 0.070 |
Why?
|
Protein Kinase Inhibitors | 1 | 2022 | 5584 | 0.070 |
Why?
|
Infant | 6 | 2013 | 35447 | 0.060 |
Why?
|
Esophageal Neoplasms | 1 | 2015 | 1606 | 0.060 |
Why?
|
Sensitivity and Specificity | 3 | 2022 | 14761 | 0.060 |
Why?
|
United States | 3 | 2022 | 70772 | 0.060 |
Why?
|
Biopsy | 2 | 2014 | 6771 | 0.060 |
Why?
|
Cytokines | 2 | 2010 | 7400 | 0.060 |
Why?
|
Child | 12 | 2012 | 78594 | 0.060 |
Why?
|
Contrast Media | 2 | 2017 | 5338 | 0.060 |
Why?
|
Osteoarthritis, Knee | 1 | 2015 | 1251 | 0.060 |
Why?
|
Male | 18 | 2022 | 354311 | 0.060 |
Why?
|
Myeloid Cells | 1 | 2009 | 815 | 0.060 |
Why?
|
Neutropenia | 1 | 2009 | 893 | 0.060 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2020 | 8971 | 0.060 |
Why?
|
Exercise Test | 1 | 2011 | 2090 | 0.060 |
Why?
|
Image Enhancement | 1 | 2014 | 2913 | 0.050 |
Why?
|
Dietary Supplements | 1 | 2016 | 3344 | 0.050 |
Why?
|
Tumor Microenvironment | 1 | 2015 | 3700 | 0.050 |
Why?
|
Tissue Distribution | 2 | 2017 | 2335 | 0.050 |
Why?
|
Losartan | 1 | 2023 | 303 | 0.050 |
Why?
|
Stem Cell Transplantation | 1 | 2010 | 1626 | 0.050 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2016 | 2446 | 0.050 |
Why?
|
Collagen Type I | 1 | 2023 | 592 | 0.050 |
Why?
|
Bioreactors | 2 | 2012 | 236 | 0.050 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2009 | 1517 | 0.040 |
Why?
|
Echocardiography | 1 | 2012 | 5117 | 0.040 |
Why?
|
Coronary Angiography | 1 | 2011 | 4598 | 0.040 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2011 | 3334 | 0.040 |
Why?
|
Ultrasonography | 1 | 2011 | 6037 | 0.040 |
Why?
|
Lactation | 1 | 2020 | 413 | 0.040 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2009 | 2927 | 0.040 |
Why?
|
Standard of Care | 1 | 2022 | 566 | 0.040 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2017 | 3572 | 0.040 |
Why?
|
Iran | 2 | 2011 | 722 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2012 | 13042 | 0.040 |
Why?
|
Interleukin-12 | 2 | 2010 | 587 | 0.040 |
Why?
|
Radiology, Interventional | 1 | 2021 | 468 | 0.040 |
Why?
|
Lactams | 1 | 2017 | 156 | 0.030 |
Why?
|
Rats | 1 | 2012 | 24248 | 0.030 |
Why?
|
Isotope Labeling | 1 | 2017 | 405 | 0.030 |
Why?
|
Muscle, Skeletal | 1 | 2010 | 4929 | 0.030 |
Why?
|
Collagen | 1 | 2023 | 2689 | 0.030 |
Why?
|
Heterocyclic Compounds, 1-Ring | 1 | 2015 | 66 | 0.030 |
Why?
|
Copper Radioisotopes | 1 | 2015 | 88 | 0.030 |
Why?
|
Immunohistochemistry | 3 | 2015 | 11395 | 0.030 |
Why?
|
Tumor Burden | 1 | 2020 | 1917 | 0.030 |
Why?
|
Workplace | 1 | 2020 | 844 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2012 | 20026 | 0.030 |
Why?
|
Pregnancy | 2 | 2020 | 29630 | 0.030 |
Why?
|
Adolescent | 5 | 2013 | 86713 | 0.030 |
Why?
|
Aminopyridines | 1 | 2017 | 549 | 0.030 |
Why?
|
MutS Homolog 2 Protein | 1 | 2013 | 200 | 0.030 |
Why?
|
Interleukin-2 | 2 | 2010 | 1904 | 0.030 |
Why?
|
Infant, Newborn | 2 | 2010 | 25903 | 0.030 |
Why?
|
Menisci, Tibial | 1 | 2015 | 270 | 0.030 |
Why?
|
Chelation Therapy | 1 | 2012 | 66 | 0.030 |
Why?
|
Genotype | 3 | 2013 | 12970 | 0.030 |
Why?
|
Indocyanine Green | 1 | 2014 | 240 | 0.030 |
Why?
|
Mice, Inbred Strains | 1 | 2015 | 1830 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 2 | 2015 | 20346 | 0.030 |
Why?
|
Radiopharmaceuticals | 1 | 2022 | 2675 | 0.030 |
Why?
|
Piebaldism | 1 | 2011 | 3 | 0.020 |
Why?
|
Coloring Agents | 1 | 2014 | 566 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2015 | 2071 | 0.020 |
Why?
|
Interferon-gamma | 2 | 2010 | 3220 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 2 | 2010 | 17635 | 0.020 |
Why?
|
Child, Preschool | 5 | 2012 | 41390 | 0.020 |
Why?
|
Integrases | 1 | 2013 | 535 | 0.020 |
Why?
|
Social Support | 1 | 2020 | 2145 | 0.020 |
Why?
|
Intestinal Neoplasms | 1 | 2013 | 320 | 0.020 |
Why?
|
Regression Analysis | 1 | 2020 | 6458 | 0.020 |
Why?
|
Macaca mulatta | 1 | 2017 | 2389 | 0.020 |
Why?
|
Time Factors | 1 | 2012 | 40195 | 0.020 |
Why?
|
Polyglycolic Acid | 1 | 2012 | 408 | 0.020 |
Why?
|
DNA Mutational Analysis | 2 | 2009 | 4179 | 0.020 |
Why?
|
Pigmentation Disorders | 1 | 2011 | 99 | 0.020 |
Why?
|
Antineoplastic Agents | 2 | 2013 | 13678 | 0.020 |
Why?
|
Urologic Surgical Procedures, Male | 1 | 2010 | 75 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2012 | 15459 | 0.020 |
Why?
|
Interleukin-6 | 2 | 2010 | 3198 | 0.020 |
Why?
|
Urothelium | 1 | 2012 | 277 | 0.020 |
Why?
|
Brain | 1 | 2016 | 26598 | 0.020 |
Why?
|
Wnt Proteins | 1 | 2013 | 721 | 0.020 |
Why?
|
Interleukin-1beta | 1 | 2015 | 989 | 0.020 |
Why?
|
Urogenital Surgical Procedures | 1 | 2009 | 35 | 0.020 |
Why?
|
Gastrointestinal Tract | 1 | 2015 | 832 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2015 | 3127 | 0.020 |
Why?
|
Antigens, CD20 | 1 | 2009 | 200 | 0.020 |
Why?
|
Body Fluids | 1 | 2010 | 319 | 0.020 |
Why?
|
Manometry | 1 | 2010 | 454 | 0.020 |
Why?
|
Oral Ulcer | 1 | 2009 | 96 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2010 | 4420 | 0.020 |
Why?
|
Quinolines | 1 | 2013 | 746 | 0.020 |
Why?
|
Gene Rearrangement | 1 | 2013 | 1173 | 0.020 |
Why?
|
Extracellular Matrix | 1 | 2015 | 1747 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2015 | 20914 | 0.020 |
Why?
|
Biofilms | 1 | 2012 | 622 | 0.020 |
Why?
|
Disease Progression | 2 | 2015 | 13364 | 0.020 |
Why?
|
Pilot Projects | 1 | 2020 | 8413 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2015 | 19270 | 0.020 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2011 | 547 | 0.020 |
Why?
|
Twins, Monozygotic | 1 | 2009 | 463 | 0.020 |
Why?
|
Imidazoles | 1 | 2013 | 1201 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2015 | 3627 | 0.020 |
Why?
|
Consanguinity | 1 | 2009 | 459 | 0.020 |
Why?
|
Diseases in Twins | 1 | 2009 | 451 | 0.020 |
Why?
|
Pyrazoles | 1 | 2017 | 1993 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2014 | 2702 | 0.020 |
Why?
|
Neprilysin | 1 | 2009 | 441 | 0.020 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2015 | 1517 | 0.020 |
Why?
|
Transcranial Magnetic Stimulation | 1 | 2016 | 1445 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2012 | 2888 | 0.020 |
Why?
|
Candidiasis | 1 | 2009 | 370 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2013 | 1522 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3500 | 0.020 |
Why?
|
Phantoms, Imaging | 1 | 2014 | 2485 | 0.020 |
Why?
|
Electromyography | 1 | 2010 | 1390 | 0.020 |
Why?
|
Lung | 1 | 2023 | 9990 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 3885 | 0.020 |
Why?
|
Eating | 1 | 2012 | 1563 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2017 | 4562 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2009 | 1875 | 0.020 |
Why?
|
Siblings | 1 | 2009 | 850 | 0.010 |
Why?
|
Neoplasms | 1 | 2013 | 21976 | 0.010 |
Why?
|
Up-Regulation | 1 | 2013 | 4194 | 0.010 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2013 | 2101 | 0.010 |
Why?
|
Predictive Value of Tests | 2 | 2010 | 15164 | 0.010 |
Why?
|
Abdomen | 1 | 2010 | 1125 | 0.010 |
Why?
|
Early Diagnosis | 1 | 2009 | 1181 | 0.010 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2013 | 2927 | 0.010 |
Why?
|
Rare Diseases | 1 | 2009 | 605 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2011 | 78758 | 0.010 |
Why?
|
Young Adult | 1 | 2009 | 57267 | 0.010 |
Why?
|
Protein Binding | 1 | 2015 | 9408 | 0.010 |
Why?
|
Regeneration | 1 | 2012 | 1498 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2012 | 6169 | 0.010 |
Why?
|
Adult | 4 | 2022 | 216658 | 0.010 |
Why?
|
Gene Frequency | 1 | 2009 | 3591 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2010 | 21904 | 0.010 |
Why?
|
Hepatitis C | 1 | 2012 | 1597 | 0.010 |
Why?
|
Abnormalities, Multiple | 1 | 2009 | 1415 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 2013 | 3700 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2010 | 5144 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2015 | 4062 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2009 | 4327 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2010 | 39223 | 0.010 |
Why?
|
Middle Aged | 2 | 2022 | 216054 | 0.010 |
Why?
|
Apoptosis | 1 | 2013 | 9657 | 0.010 |
Why?
|
Risk Factors | 2 | 2016 | 73094 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2020 | 58361 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2013 | 11626 | 0.010 |
Why?
|
Phenotype | 1 | 2009 | 16484 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2009 | 11553 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2011 | 25454 | 0.010 |
Why?
|
Aged | 1 | 2020 | 165629 | 0.000 |
Why?
|
Risk Assessment | 1 | 2009 | 23554 | 0.000 |
Why?
|
Mutation | 1 | 2009 | 29981 | 0.000 |
Why?
|